headache
HEADACHE
Headache is a very common problem presenting to primary care physicians and neurologists.
Most headaches are diagnosed based on the history & physical exam w/ no imaging or laboratory examination necessary.
Other types of headaches such as secondary headaches may require further evaluation & referral to a specialist.

Introduction

Headache

  • Very common problem presenting to primary care clinicians and neurologists
    • Almost half of adults worldwide experiences headache and 30% of them have migraine headache
    • Most common primary headache is tension-type headache while cluster headache is relatively common affecting about 1 in 1000 adults worldwide

Red Flag Signs and Symptoms which Need Further Evaluation and/or Referral

  • Worsening headache
  • Headache with fever and neck stiffness
  • Thunderclap headache
    • Sudden-onset of severe headache reaching maximum intensity within seconds to minutes
    • First or worst headache of the patient’s life (eg possible subarachnoid hemorrhage)
  • New-onset headache with:
    • Signs of systemic illness
    • Compromised immunity (eg caused by human immunodeficiency virus or immunosuppressive drug)
    • Age <20 years old and a history of malignancy
    • Age >50 years old with symptoms suggestive of temporal arteritis
    • Elderly patient with subacute cognitive change (eg possible subacute or chronic subdural hematoma)
    • History of malignancy known to metastasize to the brain
    • Vomiting without other obvious cause
    • Lyme disease
  • New-onset of severe headache in pregnancy or postpartum
  • Focal neurologic signs (not typical aura)
  • New-onset neurological deficit or cognitive dysfunction
  • Change in personality
  • Impaired level of consciousness
  • Recent head trauma (within the past 3 months)
  • Headache triggered by cough, sneeze, or valsalva
  • Headache triggered by exercise, exertion, or sexual intercourse
  • Rapid onset with strenuous exercise
  • Orthostatic headache
  • Symptoms suggestive or giant cell arteritis
  • Papilledema with altered level of consciousness and/or focal signs
  • Papilledema in an alert patient without focal neurological signs (eg possible pseudotumor cerebri)
  • Symptoms and signs of acute narrow-angle glaucoma
    • Eg non-reactive mid-dilated pupil, acutely inflamed eye, and visual disturbance with pain and nausea
  • Substantial change in the characteristics of the headache
Editor's Recommendations
Most Read Articles
Elvira Manzano, 29 May 2018
Repeat doses of the intrathecal antisense oligonucleotide nusinersen in children with infantile-onset spinal muscular atrophy (SMA) continue to demonstrate safety, according to  early data from the phase III SHINE extension study, bringing considerable hope to the SMA community.
Audrey Abella, 29 Aug 2018
The combination of the alkylating nitrosourea compound lomustine and the monoclonal antibody bevacizumab prolonged progression-free survival (PFS) in patients with progressive glioblastoma compared with either drug alone, a meta-analysis has shown.
31 Aug 2018
New drug applications approved by US FDA as of 16 - 31 August 2018 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
29 Aug 2018
The risk of traumatic brain injury (TBI) is elevated in young people with attention-deficit/hyperactivity disorder (ADHD), though long-term ADHD medication can reduce this risk, a recent study has found.